Senti Biosciences (SNTI) Shares Outstanding (Weighted Average) (2021 - 2025)

Senti Biosciences has reported Shares Outstanding (Weighted Average) for 5 years, with the latest figure at $22.5 million in Q4 2025.

• For the quarter ending Q4 2025, Shares Outstanding (Weighted Average) rose 389.2% year-over-year to $22.5 million; the trailing twelve-month figure through Dec 2025 stood at $22.5 million (up 389.2% YoY), and the FY2025 full-year result was $22.5 million, up 389.2% from the prior year.
• Shares Outstanding (Weighted Average) for Q4 2025 stood at $22.5 million, up from $20.8 million in the prior quarter.
• The five-year high for Shares Outstanding (Weighted Average) was $44.1 million in Q1 2023, with the low at $2.9 million in Q3 2021.
• Average Shares Outstanding (Weighted Average) over 5 years is $11.6 million, with a median of $4.6 million recorded in 2024.
• Year-over-year, Shares Outstanding (Weighted Average) surged 1289.7% in 2023 and slumped 89.63% in 2024.
• Tracing SNTI's Shares Outstanding (Weighted Average) over 5 years: stood at $2.9 million in 2021, then soared by 796.58% to $26.1 million in 2022, then plunged by 83.01% to $4.4 million in 2023, then grew by 3.58% to $4.6 million in 2024, then soared by 389.2% to $22.5 million in 2025.
• The last three Shares Outstanding (Weighted Average) figures came in at $22.5 million (Q4 2025), $20.8 million (Q3 2025), and $26.1 million (Q2 2025), per Business Quant data.

Peer Comparison